Physician profile
Arthur Hatch
NPI 1831414499
$1,410.01
in general payments reported to CMS, 2019-2025
14 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $458 · 2021: $187 · 2023: $119 · 2024: $228 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $779.58 | 2020-2025 | Proclaim, Prodigy |
| Medtronic USA, INC. | $137.74 | 2019-2020 | |
| Averitas Pharma INC. | $77.48 | 2024-2025 | Qutenza |
| Boston Scientific Corporation | $66.54 | 2019-2025 | Intracept Rf Probe |
| Nalu Medical, INC. | $63.21 | 2025 | Nalu Neurostimulation System |
| Bioventus LLC | $55.10 | 2020-2025 | Durolane |
| Arbor Pharmaceuticals, INC. | $54.45 | 2019-2020 | |
| Medtronic, INC. | $40.91 | 2023 | Kyphon Express II Kyphopak Tray |
| Ferring Pharmaceuticals INC. | $35.46 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $28.72 | 2024 | Iovera |
| Nevro Corp. | $20.80 | 2019 | |
| Scilex Pharmaceuticals INC. | $19.67 | 2019 | |
| Otto Bock Healthcare Lp | $18.73 | 2020 | |
| Depuy Synthes Sales INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Hatch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.